In the context of mice carrying HCC and displaying resistance to PD-1 blockade, the dual inhibition of TIGIT and PD-1 has been shown to expand the population of effector memory CD8+ T cells and elevate the ratio of CTLs to Tregs within tumors (275). The gene discussed is CD8A; the disease is hepatocellular carcinoma.